Ellington Management Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-6,900
| Closed | -$292K | – | 31 |
|
|
2020
Q1 | $292K | Sell |
6,900
-700
| -9% | -$29.6K | 0.07% | 324 |
|
|
2019
Q4 | $325K | Sell |
7,600
-400
| -5% | -$17.1K | 0.07% | 263 |
|
|
2019
Q3 | $288K | Buy |
+8,000
| New | +$288K | 0.05% | 360 |
|
|
2017
Q1 | – | Sell |
-19,200
| Closed | -$554K | – | 646 |
|
|
2016
Q4 | $554K | Buy |
+19,200
| New | +$554K | 0.08% | 184 |
|